Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 193

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease

Open access
Albert, Paul, Agusti, Alvar, Edwards, Lisa, Tal-Singer, Ruth, Yates, Julie, Bakke, Per, Celli, Bartolome R, Coxson, Harvey O, Crim, Courtney, Lomas, David A, MacNee, William, Miller, Bruce, Rennard, Stephen, Silverman, Edwin K, Vestbo, Jørgen, Wouters, Emiel, Calverley, Peter · 2012 · Thorax

Abstract

BACKGROUND: Bronchodilator responsiveness is a potential phenotypic characteristic of chronic obstructive pulmonary disease (COPD). We studied whether change in lung function after a bronchodilator is abnormal in COPD, whether stable responder subgroups can be identified, and whether these subgroups experience different clinical outcomes. METHODS: 1831 patients with COPD, 285 smoking (SC) and 228 non-smoking (NSC) controls from the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) cohort. Spirometric reversibility to 400 μg inhaled salbutamol was assessed on four occasions over 1 year. RESULTS: Forced expiratory volume in 1 s (FEV(1)) increase after salbutamol was similar in SC (mean 0.14 litres (SD 0.15)) and COPD (0.12 litres (0.15)) and was significantly greater than NSC (0.08 litres (0.14)). Reversibility status varied with repeated testing in parallel with the day-to-day variation in pre-bronchodilator FEV(1), which was similar in control subjects and patients with COPD. Absolute FEV(1) change decreased by Global initiative for chronic Obstructive Lung Disease (GOLD) stage in patients with COPD (GOLD II, mean 0.16 litres (SD 0.17); III, 0.10 litres (0.13); IV, 0.05 litres (0.08) as did chances of being classified as reversible. CT-defined emphysema was weakly related to the absolute change in FEV(1) post salbutamol. Consistently reversible patients (n=227) did not differ in mortality, hospitalisation or exacerbation experience from irreversible patients when allowing for differences in baseline FEV(1). LIMITATIONS: Reversibility only assessed with salbutamol and defined by FEV(1) criteria. The COPD population was older than the control populations. CONCLUSIONS: Post-salbutamol FEV(1) change is similar in patients with COPD and smoking controls but is influenced by baseline lung function and the presence of emphysema. Bronchodilator reversibility status varies temporally and does not distinguish clinically relevant outcomes, making it an unreliable phenotype.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/thoraxjnl-2011-201458

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 193

Metadata

Authors
Albert, P., Agusti, A., Edwards, L., Tal-Singer, R., Yates, J., Bakke, P., Celli, B. R., Coxson, H. O., Crim, C., Lomas, D. A., MacNee, W., Miller, B., Rennard, S., Silverman, E. K., Vestbo, J., Wouters, E., & Calverley, P.
Venue
Thorax
Publisher
BMJ
Published
2012-06-13
Volume
67
Issue
8
Pages
701-708
ISSN
  • 0040-6376 (ISSN-L)
  • 1468-3296
OpenAlex
W2164158986
Cited by
193
References
6
FWCI
13.52
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease. https://app.cochat.ai/papers/10.1136/thoraxjnl-2011-201458
The paper
Albert, P., Agusti, A., Edwards, L., Tal-Singer, R., Yates, J., Bakke, P., Celli, B. R., Coxson, H. O., Crim, C., Lomas, D. A., MacNee, W., Miller, B., Rennard, S., Silverman, E. K., Vestbo, J., Wouters, E., & Calverley, P. (2012). Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease. Thorax. https://doi.org/10.1136/thoraxjnl-2011-201458

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.